To which floor should a patient with atrial flutter and a ventricular rate of 118 bpm requiring glucose management be admitted?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Floor Assignment for Atrial Flutter with Rate of 118 bpm Requiring Glucose Management

A patient with atrial flutter at a ventricular rate of 118 bpm who is hemodynamically stable and requires admission solely for glucose management can be safely admitted to a general medical telemetry floor rather than an intensive care unit. 1

Hemodynamic Stability Assessment

The critical first step is determining whether this patient is hemodynamically stable:

  • Check for signs of instability: hypotension (systolic BP <90 mmHg), acute heart failure with pulmonary edema, ongoing chest pain or myocardial ischemia, or altered mental status from cerebral hypoperfusion. 1
  • If any of these are present, immediate ICU admission with synchronized cardioversion is mandatory – pharmacologic rate control must not substitute for electrical cardioversion in unstable patients. 1
  • A ventricular rate of 118 bpm, while elevated, does not automatically indicate hemodynamic instability and is considerably lower than rates requiring emergent intervention (typically >200 bpm suggests accessory pathway involvement). 2

Rationale for General Telemetry Floor Admission

For hemodynamically stable patients with controlled atrial flutter, general telemetry units provide adequate monitoring without the resource intensity of ICU care:

  • Telemetry monitoring in non-ICU settings safely identifies the small fraction of patients (approximately 1%) who develop significant arrhythmias requiring urgent intervention or ICU transfer. 3, 4
  • The primary indication for admission in this case is glucose management, not cardiac instability – the atrial flutter at 118 bpm represents a chronic rhythm issue requiring rate control rather than an acute cardiac emergency. 1
  • Studies demonstrate that only 8.1% of telemetry patients require ICU transfer, and telemetry directly modified management in just 7% of cases, suggesting that most monitored patients remain stable on general floors. 3, 4

Rate Control Strategy on the Telemetry Floor

Initiate or optimize AV-nodal blocking therapy to achieve target heart rate of 80-110 bpm:

  • Intravenous diltiazem is the preferred first-line agent for rate control in stable atrial flutter (0.25 mg/kg IV bolus over 2 minutes, then 5-15 mg/hour infusion), offering superior safety and efficacy. 1
  • Alternatively, intravenous esmolol can be used (500 mcg/kg IV bolus over 1 minute, then 50-300 mcg/kg/min infusion) due to its rapid onset and short half-life allowing precise titration. 1
  • Achieving adequate rate control in atrial flutter is more challenging than in atrial fibrillation due to less concealed AV-nodal conduction, so anticipate need for higher or repeated dosing. 1

Critical Contraindications to Monitor

Avoid calcium-channel blockers or beta-blockers if:

  • Advanced systolic heart failure is present
  • High-grade AV block or sinus node dysfunction exists without a pacemaker
  • Pre-excitation syndrome (e.g., Wolff-Parkinson-White) is suspected – in WPW, AV-nodal blocking agents can precipitate ventricular fibrillation and are absolutely contraindicated. 1

Glucose Management Considerations

The concurrent need for glucose management does not alter floor assignment unless:

  • Severe hypoglycemia or diabetic ketoacidosis creates hemodynamic instability
  • The patient requires intensive insulin drip protocols typically reserved for ICU settings
  • Notably, SGLT2 inhibitors used for glucose management may actually reduce the risk of new-onset atrial fibrillation/flutter, though this is not relevant to acute floor assignment decisions. 5, 6

Monitoring Requirements on Telemetry Floor

Continuous cardiac monitoring should detect:

  • Sudden increases in ventricular rate suggesting 1:1 AV conduction (a dangerous complication if antiarrhythmic drugs are used)
  • Development of hemodynamic instability requiring ICU transfer
  • Only 0.8% of telemetry admissions require transfer specifically due to arrhythmias identified by monitoring, reinforcing that general telemetry provides adequate surveillance. 3

When ICU Admission Would Be Required

Transfer this patient to ICU only if:

  • Hemodynamic instability develops (as defined above)
  • Ventricular rate accelerates to >200 bpm suggesting accessory pathway
  • Acute coronary syndrome or acute heart failure is diagnosed
  • Cardioversion is planned and duration of atrial flutter is unknown or >48 hours (requiring TEE or 3 weeks anticoagulation first) 1, 2

The combination of stable vital signs, controlled ventricular rate at 118 bpm, and primary admission indication being glucose management clearly supports general medical telemetry floor placement over ICU admission. 7, 3, 4

References

Guideline

Management of Rapid Atrial Flutter

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Atrial Fibrillation with Rapid Ventricular Response

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Role of telemetry monitoring in the non-intensive care unit.

The American journal of cardiology, 1995

Research

Outcomes of patients hospitalized to a telemetry unit.

The American journal of cardiology, 1994

Research

A New Hope: Sodium-Glucose Cotransporter-2 Inhibition to Prevent Atrial Fibrillation.

Journal of cardiovascular development and disease, 2022

Related Questions

What are the recommendations for operating a telemetry floor without an Intensive Care Unit (ICU)?
To what level of care (telemetry bed vs regular floor) should a 79‑year‑old woman with abdominal pain, metastatic medullary thyroid cancer, a smoking history, coronary artery disease, peripheral vascular disease, and diverticulosis be admitted?
What type of monitored hospital bed is indicated for an elderly woman with grade 2 diastolic dysfunction, infiltrative cardiomyopathy, atrial flutter with a controlled ventricular rate of 70 beats per minute, presenting with an acute cough exacerbation unresponsive to doubled oral furosemide (Lasix) for three days?
What is the management for a patient with persistent ST-Elevation Myocardial Infarction (STEMI) after Percutaneous Coronary Intervention (PCI)?
What is the management approach for concerning telemetry rhythms?
A 41-year-old male (80 kg, 170 cm, BMI ≈ 27.7) presents with post‑prandial right‑upper‑quadrant pain, ultrasound showing diffuse hepatic parenchymal changes, cholecystitis and bile stasis, borderline impaired renal function (creatinine 111 µmol/L), elevated hematocrit (51 %), eosinophilia (5.3 %), no cardiac murmurs, and a diet rich in fried, fatty, spicy foods and three eggs daily—what is the most likely diagnosis and optimal management?
What is the recommended gabapentin dosing regimen for neuropathic pain, including initial dose, titration schedule, target range, maximum dose, and adjustments for older adults or patients with moderate to severe renal impairment?
What is the recommended approach to evaluate and manage persistent thrombocytopenia (platelet count <150 × 10⁹/L for >7–14 days) in a preterm infant?
What is the appropriate management for a 55‑year‑old postmenopausal woman with central obesity, fatigue, cognitive fog, hypercholesterolemia (total cholesterol 217 mg/dL, LDL‑cholesterol 114 mg/dL), borderline high apolipoprotein B (93 mg/dL), vitamin D insufficiency (27 ng/mL), and elevated thyroid peroxidase antibodies (597 IU/mL) despite euthyroid thyroid function?
Can acitretin be prescribed to a patient with mild metabolic‑associated fatty liver disease?
What is the recommended evaluation and management for an adult with episodic migraine (fewer than 15 headache days per month) and no contraindications?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.